A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients With COPD

Clinical trial NCT06643078 · COMPLETED

Trial details

NCT number: NCT06643078
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2023-12-11
Primary completion: 2025-05-12
Enrollment: 487

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.